ELISE BOBROWSKI: Open Payments
NPI 1134521792 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,152 in 58 payments from 13 companies in 2025. Trend: 2023 $141 · 2024 $1,315 · 2025 $7,152
Speaker / faculty: $5,120Food & beverage: $1,099Travel & lodging: $933
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 21 | $6,428 |
| ABBVIE INC. | 16 | $272 |
| Janssen Biotech, Inc. | 4 | $95 |
| GENZYME CORPORATION | 4 | $77 |
| Madrigal Pharmaceuticals | 2 | $59 |
| Hologic Sales and Service, LLC | 2 | $46 |
| PFIZER INC. | 2 | $41 |
| Phathom Pharmaceuticals, Inc. | 2 | $27 |
| Sandoz Inc. | 1 | $26 |
| Mauna Kea Technologies, Inc. | 1 | $22 |
Products named: Epclusa, TREMFYA, MAVYRET, LINZESS, REZDIFFRA, SKYRIZI, RINVOQ, APTIMA.
Industry payments across TN — which companies pay providers there.
